In this presentation, Dr. Mera provides an overview of point-of-care HCV RNA testing and its role in enabling hepatitis C diagnosis and linkage to care within a single visit. He… […]
Keyword: hepatitis
Hepatitis C Elimination in Tribal Health: Expanding Access, Improving Outcomes, and Advancing Population Health | July 1, 2026
In this presentation, Dr. Brownell reviews current evidence-based approaches to hepatitis C screening, evaluation, treatment, and elimination within a tribal healthcare system. She highlights multidisciplinary strategies to expand access to care, the… […]
Hepatocellular Carcinoma (HCC) in HCV: Screening and Surveillance | June 17, 2026
In this presentation, Dr. Deming reviews the screening and prevention guidelines for hepatocellular carcinoma (HCC), describes the recommendations for HCC screening and discusses the significance of on-going surveillance. […]
Read More… from Hepatocellular Carcinoma (HCC) in HCV: Screening and Surveillance | June 17, 2026
HCV Treatment Monitoring: Keeping it Simple | November 5, 2025
In this session, Dr. Paulina Deming discusses baseline laboratories recommended for HCV treatment evaluation, identifies patients eligible for simplified monitoring and shares HCV treatment monitoring recommendations. […]
Read More… from HCV Treatment Monitoring: Keeping it Simple | November 5, 2025
Hepatitis B and D Coinfection | April 2, 2025
In this presentation, Dr. Paulina Deming, ECHO faculty member and Associate Professor of Pharmacy at the University of New Mexico Sciences Center, discusses the relationship between hepatitis B and hepatitis… […]
Read More… from Hepatitis B and D Coinfection | April 2, 2025
HCV in Pregnancy | December 4, 2024
In this presentation, Karla Thornton, MD, MPH, describes epidemiology of HCV in pregnancy, reviews the importance of testing for HCV in pregnancy, and describe early data in HCV treatment trial… […]
Use of HCV Antivirals in Patients with Swallowing Difficulties | November 6, 2024
In this presentation, Jessica Orizu, PharmD Candidate, will review the use of direct-acting antivirals (DAAs) in patients with swallowing difficulties, focusing on the use of sofosbuvir/velpatasvir (Epclusa) and glecaprevir/pibrentasvir (Mavyret).… […]
Read More… from Use of HCV Antivirals in Patients with Swallowing Difficulties | November 6, 2024
Common HCV DAA Drug Interactions | September 25, 2024
In this presentation, Dr. Brad Moran describes the interaction potential between DAA therapies and common medications. […]
Read More… from Common HCV DAA Drug Interactions | September 25, 2024
HCV Treatment Monitoring: Keeping it Simple | July 17, 2024
In this session, Dr. Paulina Deming discusses baseline laboratories recommended for HCV treatment evaluation, identifies patients eligible for simplified monitoring and shares HCV treatment monitoring recommendations. […]
Read More… from HCV Treatment Monitoring: Keeping it Simple | July 17, 2024
Approach to HBV Treatment | May 15, 2024
In this presentation Dr. Karla Thornton discusses appropriate baseline serologies for Hepatitis B Virus (HBV), identifies who should be offered treatment for HBV, and reviews the current recommended medications for… […]
